XR Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,200
Closed -$357K 86
2024
Q3
$357K Hold
2,200
0.1% 131
2024
Q2
$322K Hold
2,200
0.06% 185
2024
Q1
$348K Sell
2,200
-800
-27% -$127K 0.01% 243
2023
Q4
$470K Sell
3,000
-2,600
-46% -$399K 0.02% 273
2023
Q3
$872K Sell
5,600
-700
-11% -$116K 0.07% 182
2023
Q2
$1.04M Sell
6,300
-6,200
-50% -$1M 0.05% 156
2023
Q1
$1.94M Buy
+12,500
New +$2.02M 0.05% 113
2020
Q1
Sell
-17,000
Closed -$1K 255
2019
Q4
$1K Buy
+17,000
New +$2.31M ﹤0.01% 230
2019
Q1
Sell
-56,700
Closed -$189K 349
2018
Q4
$189K Buy
56,700
+44,900
+381% +$6.26M 0.08% 144
2018
Q3
$9K Buy
+11,800
New +$1.57M ﹤0.01% 327

Other funds holding JNJ

XR Securities's JNJ Position: Q2 2023 in Review

XR Securities sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 3,991 shares — an estimated $644K sold.

XR Securities first reported a position in JNJ in Q2 2018 and held it in 12 quarters. The position peaked at $6.89M in Q4 2018. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • XR Securities reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • XR Securities sold 3,991 Johnson & Johnson shares in Q2 2023, an estimated $644K.
  • XR Securities first reported a position in Johnson & Johnson in Q2 2018 and held it in 12 quarters.
  • XR Securities's Johnson & Johnson position peaked at $6.89M in Q4 2018.
  • 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on XR Securities's 13F filing for Q2 2023, filed 8 Aug 2023.